Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Biohaven Ltd. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 183 | 180 | −3 |
| Shares | 63.0M | 67.1M | +4.06M (+6.4%) |
| Value | $882.3M | $921.1M | +$38.8M (+4.4%) |
New holders (34)
Institutions that held Biohaven Ltd. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (37)
Institutions that held Biohaven Ltd. at the end of Q4 2022 and filed for Q1 2023 without it.